As the year comes to a close, it is an appropriate time to reflect on the scientific milestones that continue to shape the future of urology and patient care.
Earlier this year, Vertica® was included in a comprehensive review on Erectile Dysfunction published in European Urology – one of the world’s most respected peer-reviewed journals in the field. This inclusion remains an important marker of Vertica’s clinical credibility and ongoing relevance within modern urological practice.
Recognition Within a Landmark Clinical Review
The European Urology review, authored by leading international urologists, examined established and emerging approaches to erectile dysfunction management.
Within this expert analysis, Vertica was referenced as an innovative home-use medical device employing low-intensity radiofrequency therapy to address an underlying physiological contributor to erectile dysfunction – veno-occlusive dysfunction.
Notably, Vertica was one of only a small number of new devices acknowledged in the review, reflecting both the novelty of its mechanism and the strength of its clinical foundation.
Clinical Evidence Referenced
The review highlighted clinical data from a 32-patient study, which demonstrated:
- Significant improvements in erectile hardness and function, measured through increases in IIEF (International Index of Erectile Function) scores
- A strong safety and tolerability profile, with no major adverse effects reported
- A non-invasive, regenerative mechanism of action, targeting collagen structure within the corpora cavernosa rather than providing symptomatic support alone
This approach represents a shift toward therapies designed to influence tissue quality and vascular function, rather than relying exclusively on medication.
Why This Recognition Matters
It reflects a level of scientific scrutiny and clinical relevance that continues to matter well beyond publication.
For clinicians and patients alike, it reinforces that Vertica is grounded in peer-reviewed evidence and aligned with evolving thinking in erectile dysfunction care – particularly for those seeking non-pharmacological, home-based treatment options.
Looking Forward into 2026
As research continues and clinical experience grows, Vertica’s recognition within the scientific literature remains a key reference point in its development.
As we move into the new year, this milestone serves as a reminder of the importance of rigorous science, clinical evaluation, and thoughtful innovation in improving patient outcomes.
For further information about the clinical evidence behind Vertica, speak to our UK-based team.
